MARCH 2024 NEUROENDOCRINE CANCER UK QUARTERLY NEWSLETTER

21st ANNUAL ENETS NIKIE, LEANNE AND LISA REP This year’s ENETs was a bit special - ENETs as a formal professional participants (895 onsite, 269 online) attending the annual conference The UK’s own Professor Caplin, our charity’s patron, was one of the s chair, for a 2-year term of office, in 2014. Reflecting on the past 20 years, amongst his personal highlights, he in and their representation on the ENETs Advisory Board and the promo “Patients are central to the cause of ENETs. Patient advocacy is s ‘ownership’ of research and ethical approvals. We need to work t in ENETs can achieve even more”.

The Annual INCA/EN patient advocates and specialists in neuroen time, less formally, wi CLICK HERE to read

ENETs 2024 marked a record year for abstracts - with 317 abstract chosen for oral presentation (including those we submitted) plus 12 ab Open Access to all accepted abstracts is available by CLICKING HER booklet) But back to Day One, which is usually dedicated to ENETs Postgradua different: it provides an overview on where we’re at with diagnostics, tr and guidelines - highlighting sessions that would take place over the f PG course included a session on whether “epidemiology affects the ca - so please continue your fantastic participation in our surveys and stu Professor Thakker on MEN syndromes (1-5), as well as an exploration developments in neuroendocrine cancer care. As you’ll see from the p understanding and approaching this.

8

Made with FlippingBook flipbook maker